Safety of the extension of use of oleoresin from <i>Haematococcus pluvialis</i> containing astaxanthin as a novel food pursuant to Regulation (EU) 2015/2283.

ABSTRACT: Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on an extension of use for the Novel Food (NF) 'oleoresin from Haematococcus (H.) pluvialis containing astaxanthin (ATX)' pursuant to Regulation (EU) 2015/2283. The NF is already authorised under Regulation (EU) 2015/2283 as an ingredient for use in food supplements (FS) as defined in Directive 2002/46/EC. The NF is produced by supercritical CO₂ extraction of the homogenised and dried biomass of cultivated H. pluvialis and contains approximately 10% w/w ATX With the present dossier, the applicant seeks authorisation for an extension of use of the NF for the use in dairy analogues, including beverage whiteners and fruit

SUBMITTER: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 

PROVIDER: S-EPMC12673279 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature